RecruitingNCT06655701

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis: The Intersection of Muscle Loss and Pelvic Dysfunction


Sponsor

Beylikduzu State Hospital

Enrollment

100 participants

Start Date

Nov 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.


Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 75 Years

Inclusion Criteria5

  • Postmenopausal women with DXA measurements performed within the last 6 months.
  • Based on DXA measurements:
  • Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic).
  • Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group.
  • Aged 50-75 years

Exclusion Criteria5

  • Refusal to participate in the study.
  • History of neurological diseases, infections, surgeries, or trauma that could cause urinary incontinence or muscle loss.
  • Presence of psychiatric disorders.
  • Cognitive impairments.
  • Use of medications that could affect the study results.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTNo intervention

No intervention


Locations(1)

Beylikdüzü State Hospital

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06655701


Related Trials